CHICAGO, IL – February 7, 2017 – SAMDI Tech, Inc. and Aptuit, LLC are partnering to broaden their portfolio of assay development and high-throughput drug discovery services in Europe and North America. The partnership provides early-stage drug discovery researchers with access to SAMDI Tech’s unique label-free platform as well as Aptuit’s broad assay collection and lead-like library of over 400,000 compounds.samdi logo.png

Read full press release from SAMDI Tech news site
(published February 7, 2017)